Investigating Markers of the NLRP3 Inflammasome Pathway in Alzheimer’s Disease: A Human Post-Mortem Study
Neuroinflammatory mechanisms with glial cell activation have been implicated in the pathogenic process of Alzheimer’s disease (AD). Activation of the NLRP3 inflammasome is an essential component of the neuroinflammatory response. A role for NLRP3 activation in AD is supported by both in vitro and in...
Guardado en:
Autores principales: | Hao Tang, Michael Harte |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5e00143ae72843f9811f3164dd297d4f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
NLRP3 Inflammasome Blocking as a Potential Treatment of Central Insulin Resistance in Early-Stage Alzheimer’s Disease
por: Yulia K. Komleva, et al.
Publicado: (2021) -
Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer’s Disease
por: Francesca La Rosa, et al.
Publicado: (2021) -
Spotlight on the NLRP3 inflammasome pathway
por: Groslambert M, et al.
Publicado: (2018) -
TRPM2 contributes to neuroinflammation and cognitive deficits in a cuprizone-induced multiple sclerosis model via NLRP3 inflammasome
por: Yu Shao, et al.
Publicado: (2021) -
Post-Mortem Brain Weight Reference Range for a Select South African Population
por: Govender,S, et al.
Publicado: (2018)